Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Edwards Lifesciences
Acquired Company
Vectorious Medical Technologies
Description
Edwards Lifesciences has finalized its $497 million acquisition of Vectorious Medical Technologies. This transaction follows a previous investment where Edwards acquired a 52% stake. With this deal, Edwards now fully owns Vectorious, which specializes in heart failure treatment technology. The acquisition aims to enhance Edwards' offerings in the medical device sector.
Fundz sees it the moment Edwards Lifesciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Vectorious Medical Technologies?
Vectorious Medical Technologies was acquired by Edwards Lifesciences, based in Irvine. The deal was reported on September 4, 2025. Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is privately held and operates in Manufacturing.
When did Edwards Lifesciences acquire Vectorious Medical Technologies?
Edwards Lifesciences's acquisition of Vectorious Medical Technologies was reported on September 4, 2025. Edwards Lifesciences has finalized its $497 million acquisition of Vectorious Medical Technologies. This transaction follows a previous investment where Edwards acquired a 52% stake. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Vectorious Medical Technologies do?
Vectorious Medical Technologies develops novel treatment for heart failure patients which is based on physician directed, patients’ self-management paradigm. It is privately held, operating in Biotechnology, and is based in Tel Aviv.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.